Pseudomonas aeruginosa pneumonia

J Garau, L Gomez - Current opinion in infectious diseases, 2003 - journals.lww.com
P. aeruginosa continues to be a serious problem worlwide as a cause of respiratory tract
infections in selected populations. Microbiologic diagnosis remains difficult and plagued …

Setting antimicrobial susceptibility testing breakpoints: a primer for pediatric infectious diseases specialists on the Clinical and Laboratory Standards Institute …

VM Pierce, AJ Mathers - Journal of the Pediatric Infectious …, 2022 - academic.oup.com
Breakpoints are the values used by clinical microbiology laboratories to interpret the results
of antimicrobial susceptibility testing (AST) and classify isolates as susceptible or resistant …

Breaking down the breakpoints: rationale for the 2022 Clinical and Laboratory Standards Institute revised piperacillin-tazobactam breakpoints against …

PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
Piperacillin-tazobactam (PTZ) is one of the most common antibiotics administered to
hospitalized patients. Its broad activity against gram-negative, gram-positive, and anaerobic …

Pharmacodynamic profiling of piperacillin in the presence of tazobactam in patients through the use of population pharmacokinetic models and Monte Carlo …

TP Lodise Jr, B Lomaestro, KA Rodvold… - Antimicrobial agents …, 2004 - Am Soc Microbiol
The primary objectives of this analysis were to determine which pharmacokinetic model
most accurately describes the elimination pathways for piperacillin in the presence of …

β-Lactam antibiotics targeting PBP1 selectively enhance daptomycin activity against methicillin-resistant Staphylococcus aureus

AD Berti, G Sakoulas, V Nizet, R Tewhey… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The activity of daptomycin (DAP) against methicillin-resistant Staphylococcus aureus
(MRSA) is enhanced in the presence of subinhibitory concentrations of antistaphylococcal β …

Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients

JM Conil, B Georges, O Mimoz, E Dieye, S Ruiz… - Intensive care …, 2006 - Springer
Objective To explore the effects of renal function estimated by measured creatinine
clearance (Cl CR) on trough serum concentration (C min) of piperacillin given to critically ill …

In Vivo Comparison of CXA-101 (FR264205) with and without Tazobactam versus Piperacillin-Tazobactam Using Human Simulated Exposures against …

CC Bulik, PR Tessier, RA Keel… - Antimicrobial agents …, 2012 - Am Soc Microbiol
ABSTRACT CXA-101 is a novel antipseudomonal cephalosporin with enhanced activity
against Gram-negative organisms displaying various resistance mechanisms. This study …

Deconstructing the 2023 Clinical and Laboratory Standards Institute Revised Piperacillin-Tazobactam Breakpoints Against Pseudomonas aeruginosa

PD Tamma, PNA Harris, AJ Mathers… - Clinical Infectious …, 2023 - academic.oup.com
TO THE EDITOR—In January 2023, the Clinical and Laboratory Standards Institute (CLSI)
revised the piperacillintazobactam (PTZ) interpretive criteria against Pseudomonas …

Pharmacokinetic and pharmacodynamic evaluation of two dosing regimens for piperacillin‐tazobactam

MK Kim, B Capitano, HM Mattoes… - … : The Journal of …, 2002 - Wiley Online Library
Study Objective. To compare the pharmacokinetic and pharmacodynamic profiles of two
dosing regimens for piperacillin‐tazobactam against commonly encountered pathogens …

A simple and rapid RP-HPLC method for the simultaneous determination of piperacillin and tazobactam in human plasma

JJ Veillette, SA Winans, SC Forland… - … of Pharmaceutical and …, 2016 - Elsevier
A rapid and sensitive reverse phase HPLC (RP-HPLC) method for the simultaneous
quantitation of piperacillin and tazobactam in human plasma has been developed and …